美国食品和药品管理局还没有批准阿瓦斯汀用于眼部治疗，使用它来代替雷珠单抗可能会产生额外的安全风险，尽管这一风险也许很轻微。

The Food and Drug Administration has not approved Avastin for use in the eye, and using it rather than the alternative, Lucentis, might carry an additional, although slight, safety risk.

youdao

世界卫生组织已就该病的临床治疗和管理制定和分发指导。

WHO has developed and distributed guidance on clinical treatment and management of the disease.

youdao

最近的研究表明，患者与医疗从业者(HCP)的互动的加强与成功的治疗和管理密切相关。

Recent studies have shown that an increase in patient-healthcare practitioner (HCP) interaction is linked to the successful treatment and management of diabetes.

youdao